speb/financial-data huggingface dataset:
Financial ratios for CRMD — quarterly report dated 2025-09-30
Total revenue: 104275289
Gross profit: 93080673
Operating income: 51345966
Net income: 108562980
Capital expenditures: 505774
Operating cash flow: 30856502
Depreciation & amortization: 3790466
Net tangible assets: -33397570
Owner earnings: 111847672
Return on net tangible assets (%): -334.89763476803853
Capex to operating income (%): 0.9850316186475097
Buffett classification: The Great
Stock price: 11.63
P/E ratio: 6.122023223329458
Shares outstanding: 78451891
Book value: 374129406
P/B ratio: 2.4387163310279867
Market cap (USD): 912395492.33
Debt to equity: 0.39804624980480685
Current ratio: 1.9419926612830374
Quick ratio: 1.7256218558351795
Effective tax rate (%): -106.48701394764754
Interest coverage ratio: 54.148588651420205
COGS to revenue (%): 10.735636513076459
R&D to revenue (%): 4.888640490845344
SG&A to revenue (%): 35.13494266124738
Free cash flow (dilution-adjusted): 26285187
Buyback yield (%): 0
Retained earnings: -190595174
Inventory turnover: 0.3871343728463939
Receivables turnover: 0.6514556987924597
Capitalized R&D asset: 7787949.03
ROCI (R&D-adjusted, %): 8.458455912489802
Rosenberg metric: 22.60045343100631
FCF margin (%): 25.20749379078681
Revenue growth (%): 162.4149786633495
Rule of 40 score: 187.6224724541363
Financial ratios for CRMD — quarterly report dated 2025-12-31
Total revenue: 128615264
Gross profit: 107308042
Operating income: 59126248
Net income: 14020141
Capital expenditures: 1720104
Operating cash flow: 94461181
Depreciation & amortization: 10433651
Net tangible assets: -3767000
Owner earnings: 22733688
Return on net tangible assets (%): -603.4958322272365
Capex to operating income (%): 2.909205400620043
Buffett classification: The Great
Stock price: 11.63
P/E ratio: 5.595626761375428
Shares outstanding: 78451891
Book value: 405307000
P/B ratio: 2.2511219700868725
Market cap (USD): 912395492.33
Debt to equity: 0.3674103827469054
Current ratio: 2.1062323190010845
Quick ratio: 1.935714326701823
Effective tax rate (%): 75.1620438888294
Interest coverage ratio: 32.53917303540462
COGS to revenue (%): 16.566635512251484
R&D to revenue (%): 6.686770086636063
SG&A to revenue (%): 30.775186217399515
Free cash flow (dilution-adjusted): 89152053
Buyback yield (%): 0
Retained earnings: -176575000
Inventory turnover: 0.7170286041189932
Receivables turnover: 0.7511126009589273
Capitalized R&D asset: 12821722.450000001
ROCI (R&D-adjusted, %): 9.379684572119222
Rosenberg metric: 2.790969514544366
FCF margin (%): 69.31685262489529
Revenue growth (%): 23.342035522912816
Rule of 40 score: 92.65888814780811
Financial ratios for CRMD — annual report dated 2025-12-31
Total revenue: 311709000
Gross profit: 275748000
Operating income: 150141000
Net income: 163055000
Capital expenditures: 2260000
Operating cash flow: 175046000
Depreciation & amortization: 14549000
Net tangible assets: -3767000
Owner earnings: 175344000
Return on net tangible assets (%): -4654.738518715158
Capex to operating income (%): 1.5052517300404287
Buffett classification: The Great
Stock price: 11.63
P/E ratio: 5.59563026175217
Shares outstanding: 78451891
Book value: 405307000
P/B ratio: 2.2511219700868725
Market cap (USD): 912395492.33
Debt to equity: 0.3674103827469054
Current ratio: 2.1062323190010845
Quick ratio: 1.935714326701823
Effective tax rate (%): -8.69173954778157
Interest coverage ratio: 53.968727534148094
COGS to revenue (%): 11.536721750093838
R&D to revenue (%): 6.202259158381695
SG&A to revenue (%): 34.09397867883186
Free cash flow (dilution-adjusted): 158954000
Buyback yield (%): 0
Retained earnings: -176575000
Inventory turnover: 1.2101561448377978
Receivables turnover: 1.8203792493269404
Capitalized R&D asset: 26315331.25
ROCI (R&D-adjusted, %): 23.198662930401166
Rosenberg metric: 59.732623033992894
FCF margin (%): 50.99435691622636
Revenue growth (%): 617.033952889216
Rule of 40 score: 668.0283098054424
Financial ratios for CURA.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.69291338582677
Shares outstanding: 232910632
Market cap (USD): 6217063326.614173
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURA.TO — annual report dated 2022-12-31
Total revenue: 1275420000
Gross profit: 626419000
Operating income: 64988000
Net income: -370099000
Capital expenditures: 134643000
Operating cash flow: 46403000
Depreciation & amortization: 165641000
Net tangible assets: -558727000
Owner earnings: -339101000
Capex to operating income (%): 207.18132578322152
Buffett classification: The Gruesome
Stock price: 12.860294117647056
Shares outstanding: 232910632
Book value: 1400818000
P/B ratio: 2.138250101474323
Market cap (USD): 2995299230.647058
Debt to equity: 0.6629904812759402
Current ratio: 1.3130751024416947
Quick ratio: 0.8405512127969602
Interest coverage ratio: 0.7315008667071881
COGS to revenue (%): 50.88527700678992
SG&A to revenue (%): 35.1176083172602
Free cash flow (dilution-adjusted): -116257000
Buyback yield (%): 0
Retained earnings: -859554000
Inventory turnover: 2.764270685146221
Receivables turnover: 28.23037251820536
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.227376981531978
FCF margin (%): -9.11519342647912
Rule of 40 score: -9.11519342647912
Financial ratios for CURA.TO — annual report dated 2023-12-31
Total revenue: 1346632000
Gross profit: 614449000
Operating income: 42883000
Net income: -281197000
Capital expenditures: 65446000
Operating cash flow: 75261000
Depreciation & amortization: 211914000
Net tangible assets: -748431000
Owner earnings: -134729000
Capex to operating income (%): 152.6152554625376
Buffett classification: The Gruesome
Stock price: 12.522727272727273
Shares outstanding: 232910632
Book value: 1171292000
P/B ratio: 2.490135955384776
Market cap (USD): 2916676323.4545455
Debt to equity: 0.7543353834910509
Current ratio: 0.8473161766194229
Quick ratio: 0.41027540614613567
Interest coverage ratio: 0.4271981032456018
COGS to revenue (%): 54.371424412905675
R&D to revenue (%): 0.1055225184014638
SG&A to revenue (%): 32.28669747934105
Free cash flow (dilution-adjusted): -15052000
Buyback yield (%): 0
Retained earnings: -1140751000
Inventory turnover: 3.391101971627461
Receivables turnover: 21.48423739629866
Capitalized R&D asset: 1421000
ROCI (R&D-adjusted, %): 1.6832164409914172
FCF margin (%): -1.117751546079404
Revenue growth (%): 5.583415659155415
Rule of 40 score: 4.465664113076011
Financial ratios for CURA.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.155555555555555
Shares outstanding: 232910632
Market cap (USD): 2132426230.7555554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURA.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.699300699300699
Shares outstanding: 232910632
Market cap (USD): 1094517095.8321679
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURA.TO — annual report dated 2024-12-31
Total revenue: 1334299000
Gross profit: 640777000
Operating income: 24743000
Net income: -238169000
Capital expenditures: 91056000
Operating cash flow: 163624000
Depreciation & amortization: 248017000
Net tangible assets: -853067000
Owner earnings: -81208000
Capex to operating income (%): 368.00711312290343
Buffett classification: The Gruesome
Stock price: 4.699300699300699
Shares outstanding: 232910632
Book value: 993393000
P/B ratio: 1.1017966664071197
Market cap (USD): 1094517095.8321679
Debt to equity: 0.8595017279163433
Current ratio: 1.1197138622156344
Quick ratio: 0.5604897853966617
Interest coverage ratio: 0.24591516259839388
COGS to revenue (%): 51.97650601551827
R&D to revenue (%): 0.10649786891843582
SG&A to revenue (%): 32.87096820128022
Free cash flow (dilution-adjusted): 40490000
Buyback yield (%): 0
Retained earnings: -1356174000
Inventory turnover: 3.1968820440957515
Receivables turnover: 20.070079119160074
Capitalized R&D asset: 2373070
ROCI (R&D-adjusted, %): 0.9834294784820437
Rosenberg metric: 18.52779732582688
FCF margin (%): 3.034552225550645
Revenue growth (%): -0.9158404077728733
Rule of 40 score: 2.1187118177777715
Financial ratios for CURA.TO — quarterly report dated 2025-03-31
Total revenue: 306624000
Gross profit: 155566000
Operating income: 9366000
Net income: -60246000
Capital expenditures: 15877000
Operating cash flow: 38429000
Depreciation & amortization: 53066000
Net tangible assets: -886423000
Owner earnings: -23057000
Capex to operating income (%): 169.5174033739056
Buffett classification: The Gruesome
Stock price: 2.7902097902097904
Shares outstanding: 232910632
Book value: 963100000
P/B ratio: 0.6747684826605229
Market cap (USD): 649869525.6503497
Debt to equity: 0.8790333298722874
Current ratio: 1.410114757882687
Quick ratio: 0.697891731044711
Interest coverage ratio: 0.37100415923945335
COGS to revenue (%): 49.264897724900855
R&D to revenue (%): 0.10925433103736173
SG&A to revenue (%): 35.85205332915884
Free cash flow (dilution-adjusted): 17502000
Buyback yield (%): 0
Retained earnings: -1417237000
Inventory turnover: 0.6706922349451886
Receivables turnover: 4.652514983688643
Capitalized R&D asset: 335000
ROCI (R&D-adjusted, %): 0.3644013060584631
FCF margin (%): 5.707968065122103
Rule of 40 score: 5.707968065122103
Financial ratios for CURA.TO — quarterly report dated 2025-06-30
Total revenue: 314520000
Gross profit: 152553000
Operating income: 3285000
Net income: -65022000
Capital expenditures: 15182000
Operating cash flow: 8516000
Depreciation & amortization: 55931000
Net tangible assets: -824512000
Owner earnings: -24273000
Capex to operating income (%): 462.16133942161343
Buffett classification: The Gruesome
Stock price: 2.5182481751824817
Shares outstanding: 232910632
Book value: 935259000
P/B ratio: 0.6271276448712052
Market cap (USD): 586526774.0145985
Debt to equity: 0.9013717055917131
Current ratio: 1.4681013686196767
Quick ratio: 0.6951298158454152
Interest coverage ratio: 0.12772161741835147
COGS to revenue (%): 51.496566196108354
R&D to revenue (%): 0.0817118148289457
SG&A to revenue (%): 35.757344524990465
Free cash flow (dilution-adjusted): -15347000
Buyback yield (%): 0
Retained earnings: -1470396000
Inventory turnover: 0.7149787669842055
Receivables turnover: 4.36166967133546
Capitalized R&D asset: 481450
ROCI (R&D-adjusted, %): 0.12745377169834887
Rosenberg metric: -8.99402985074627
FCF margin (%): -4.879498918987664
Revenue growth (%): 2.5751408891671885
Rule of 40 score: -2.304358029820475
Financial ratios for CURA.TO — quarterly report dated 2025-09-30
Total revenue: 320244000
Gross profit: 159741000
Operating income: 4031000
Net income: -56684000
Capital expenditures: 16106000
Operating cash flow: 48438000
Depreciation & amortization: 54372000
Net tangible assets: -853599000
Owner earnings: -18418000
Capex to operating income (%): 399.5534606797321
Buffett classification: The Gruesome
Stock price: 8.266187050359713
Shares outstanding: 232910632
Book value: 886230000
P/B ratio: 2.1724415220986613
Market cap (USD): 1925282850.1294966
Debt to equity: 0.9290748451304967
Current ratio: 1.4715651063089816
Quick ratio: 0.7053545750650427
Interest coverage ratio: 0.1589197713384585
COGS to revenue (%): 50.11897178401469
R&D to revenue (%): 0.08150035597856635
SG&A to revenue (%): 36.38475662307491
Free cash flow (dilution-adjusted): 21552000
Buyback yield (%): 0
Retained earnings: -1527427000
Inventory turnover: 0.700510206308402
Receivables turnover: 4.452657045132226
Capitalized R&D asset: 543740
ROCI (R&D-adjusted, %): 0.15504663274757532
Rosenberg metric: 27.96887159533074
FCF margin (%): 6.729868475287592
Revenue growth (%): 1.8199160625715374
Rule of 40 score: 8.549784537859129
Financial ratios for CURA.TO — quarterly report dated 2025-12-31
Total revenue: 323364000
Gross profit: 163554000
Operating income: 10308000
Net income: -99911000
Capital expenditures: 15588000
Operating cash flow: 42323000
Depreciation & amortization: 52673000
Net tangible assets: -889882000
Owner earnings: -62826000
Capex to operating income (%): 151.22235157159486
Buffett classification: The Gruesome
Stock price: 7.467153284671532
Shares outstanding: 232910632
Book value: 840281000
P/B ratio: 2.0697592719265607
Market cap (USD): 1739179390.7737224
Debt to equity: 0.9841529202730991
Current ratio: 1.5243005769348383
Quick ratio: 0.7597362001128047
Interest coverage ratio: 0.42076904237080576
COGS to revenue (%): 49.4210858351579
R&D to revenue (%): -0.014843952944669165
SG&A to revenue (%): 36.50437278113829
Free cash flow (dilution-adjusted): 13614000
Buyback yield (%): 0
Retained earnings: -1587244000
Inventory turnover: 0.7101972251602066
Receivables turnover: 3.993725916411422
Capitalized R&D asset: 211680
ROCI (R&D-adjusted, %): 0.39602081835581554
Rosenberg metric: 14.60919540229885
FCF margin (%): 4.210116153931792
Revenue growth (%): 0.9742571289391839
Rule of 40 score: 5.184373282870975
Financial ratios for CURA.TO — annual report dated 2025-12-31
Total revenue: 1268135000
Gross profit: 631022000
Operating income: 25450000
Net income: -270447000
Capital expenditures: 62753000
Operating cash flow: 137706000
Depreciation & amortization: 216042000
Net tangible assets: -889882000
Owner earnings: -117158000
Capex to operating income (%): 246.573673870334
Buffett classification: The Gruesome
Stock price: 7.467153284671532
Shares outstanding: 232910632
Book value: 840281000
P/B ratio: 2.0697592719265607
Market cap (USD): 1739179390.7737224
Debt to equity: 0.9841529202730991
Current ratio: 1.5243005769348383
Quick ratio: 0.7597362001128047
Interest coverage ratio: 0.2524075414811215
COGS to revenue (%): 50.240155819372546
R&D to revenue (%): 0.06347904600062296
SG&A to revenue (%): 36.121863997129644
Free cash flow (dilution-adjusted): 37321000
Buyback yield (%): 0
Retained earnings: -1587244000
Inventory turnover: 2.8313364915430492
Receivables turnover: 15.662175180318151
Capitalized R&D asset: 2226000
ROCI (R&D-adjusted, %): 0.9806935824089801
Rosenberg metric: -6.864883884588318
FCF margin (%): 2.9429831997381983
Revenue growth (%): -4.95870865525643
Rule of 40 score: -2.015725455518232
Financial ratios for ELM.V — annual report dated 2022-05-31
Total revenue: 1647785.8267716535
Operating income: 424443.3070866142
Net income: -17253.543307086613
Capital expenditures: 4333.858267716535
Operating cash flow: -526498.4251968504
Depreciation & amortization: 48659.84251968504
Net tangible assets: -391710.23622047243
Owner earnings: 27072.440944881888
Capex to operating income (%): 1.021068820112681
Buffett classification: The Great
Stock price: 0.05511811023622048
Shares outstanding: 70478299
Book value: -370334.64566929126
Market cap (USD): 3884630.6535433074
Debt to equity: -5.196629989900602
Current ratio: 6.128212806308329
Quick ratio: 6.128212806308329
Interest coverage ratio: 0.8152828382284214
COGS to revenue (%): 0
SG&A to revenue (%): 63.51137866705405
Free cash flow (dilution-adjusted): -530832.2834645669
Buyback yield (%): 0
Retained earnings: -8414335.433070866
Receivables turnover: 2.1346139526438783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.310186545612986
FCF margin (%): -32.214883441774404
Rule of 40 score: -32.214883441774404
Financial ratios for ELM.V — annual report dated 2023-05-31
Total revenue: 780922.0588235294
Operating income: -299634.5588235294
Net income: -436488.2352941176
Capital expenditures: 3779.411764705882
Operating cash flow: 225741.17647058822
Depreciation & amortization: 7186.029411764705
Net tangible assets: -453849.99999999994
Owner earnings: -433081.6176470588
Buffett classification: The Gruesome
Stock price: 0.007352941176470588
Shares outstanding: 70478299
Book value: -433888.9705882352
Market cap (USD): 518222.7867647059
Debt to equity: -2.9370196699142
Current ratio: 2.130613336503031
Quick ratio: 2.130613336503031
Interest coverage ratio: -0.9404877575936615
COGS to revenue (%): 0
SG&A to revenue (%): 114.8184555587569
Free cash flow (dilution-adjusted): 221961.76470588235
Buyback yield (%): 0
Retained earnings: -8293992.647058823
Receivables turnover: 6.662112572686727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.65161931524898
FCF margin (%): 28.423036870064987
Revenue growth (%): -52.60779367464799
Rule of 40 score: -24.184756804583007
Financial ratios for ELM.V — annual report dated 2024-05-31
Total revenue: 760625.5474452554
Operating income: -87529.92700729927
Net income: -349171.5328467153
Capital expenditures: 10673.722627737225
Operating cash flow: -234398.54014598537
Depreciation & amortization: 7961.313868613138
Net tangible assets: -799708.7591240875
Owner earnings: -351883.94160583935
Buffett classification: The Gruesome
Stock price: 0.0072992700729927005
Shares outstanding: 70478299
Book value: -779893.4306569343
Market cap (USD): 514440.1386861314
Debt to equity: -1.8248216582089636
Current ratio: 0.6232400693733415
Quick ratio: 0.6232400693733415
Interest coverage ratio: -0.27308439436414444
COGS to revenue (%): 0
SG&A to revenue (%): 96.50259054926937
Free cash flow (dilution-adjusted): -245072.2627737226
Buyback yield (%): 0
Retained earnings: -8582624.08759124
Receivables turnover: 10.339405665525623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.606964383785474
FCF margin (%): -32.21983058508316
Revenue growth (%): -2.599044443545486
Rule of 40 score: -34.818875028628646
Financial ratios for ELM.V — quarterly report dated 2024-11-30
Total revenue: 188770.7142857143
Operating income: 15846.428571428572
Net income: -25765
Capital expenditures: 1485.7142857142858
Operating cash flow: -8052.857142857143
Depreciation & amortization: 1899.2857142857144
Net tangible assets: -871567.142857143
Owner earnings: -25351.428571428572
Capex to operating income (%): 9.375704304710391
Buffett classification: The Great
Stock price: 0.0071428571428571435
Shares outstanding: 70478299
Book value: -852176.4285714286
Market cap (USD): 503416.42142857146
Debt to equity: -1.7333835129714086
Current ratio: 0.3811079520370141
Quick ratio: 0.3811079520370141
Interest coverage ratio: 0.29094318837538685
COGS to revenue (%): 0
SG&A to revenue (%): 80.35750097434908
Free cash flow (dilution-adjusted): -9538.57142857143
Buyback yield (%): 0
Retained earnings: -8487705.714285715
Receivables turnover: 2.848233049888454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.535547379934374
FCF margin (%): -5.052993238206593
Rule of 40 score: -5.052993238206593
Financial ratios for ELM.V — quarterly report dated 2025-02-28
Total revenue: 186450
Operating income: 32624.30555555556
Net income: -8864.583333333334
Capital expenditures: 0
Operating cash flow: 25670.13888888889
Depreciation & amortization: 1846.5277777777778
Net tangible assets: -841441.6666666667
Owner earnings: -7018.055555555557
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.006944444444444445
Shares outstanding: 70478299
Book value: -822589.5833333333
Market cap (USD): 489432.6319444445
Debt to equity: -1.7980201413388786
Current ratio: 0.45699239321240487
Quick ratio: 0.45699239321240487
Interest coverage ratio: 0.6172432368514408
COGS to revenue (%): 0
SG&A to revenue (%): 80.47547748875182
Free cash flow (dilution-adjusted): 25670.13888888889
Buyback yield (%): 0
Retained earnings: -8246020.833333334
Receivables turnover: 6.267080600359469
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.969860718222575
FCF margin (%): 13.767840648371624
Revenue growth (%): -1.2293825843143065
Rule of 40 score: 12.538458064057318
Financial ratios for ELM.V — annual report dated 2025-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007246376811594204
Shares outstanding: 70478299
Market cap (USD): 510712.31159420294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELM.V — quarterly report dated 2025-08-31
Total revenue: 201744.52554744523
Operating income: 30958.39416058394
Net income: 99357.66423357664
Capital expenditures: 1820.4379562043794
Operating cash flow: -50066.42335766423
Depreciation & amortization: 1181.021897810219
Net tangible assets: -547929.1970802919
Owner earnings: 98718.24817518248
Return on net tangible assets (%): -18.016606653052037
Capex to operating income (%): 5.88027255794214
Buffett classification: The Great
Stock price: 0.0072992700729927005
P/E ratio: 1.2944148361739642
Shares outstanding: 70478299
Book value: -528113.8686131386
Market cap (USD): 514440.1386861314
Debt to equity: -2.3279485180700914
Current ratio: 0.36132567896044215
Quick ratio: 0.36132567896044215
Interest coverage ratio: 0.5478654007621262
COGS to revenue (%): 0
SG&A to revenue (%): 82.5579796664134
Free cash flow (dilution-adjusted): -51886.86131386861
Buyback yield (%): 0
Retained earnings: -8637067.15328467
Receivables turnover: 6.269337204554734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.41438356520825
FCF margin (%): -25.71909258656247
Revenue growth (%): 8.203017188224846
Rule of 40 score: -17.516075398337627
Financial ratios for ELM.V — quarterly report dated 2025-11-30
Total revenue: 217332.85714285716
Operating income: 48137.14285714286
Net income: 25337.857142857145
Capital expenditures: 1642.857142857143
Operating cash flow: 1256.4285714285716
Depreciation & amortization: 1335
Net tangible assets: -516458.5714285715
Owner earnings: 25030.000000000004
Return on net tangible assets (%): -4.846468116651591
Capex to operating income (%): 3.412867996201329
Buffett classification: The Great
Stock price: 0.0071428571428571435
P/E ratio: 5.589420732926414
Shares outstanding: 70478299
Book value: -497067.8571428573
Market cap (USD): 503416.42142857146
Debt to equity: -2.4802894114773055
Current ratio: 0.46466662213464255
Quick ratio: 0.46466662213464255
Effective tax rate (%): 0
Interest coverage ratio: 1.536
COGS to revenue (%): 0
SG&A to revenue (%): 64.97768400018406
Free cash flow (dilution-adjusted): -386.42857142857144
Buyback yield (%): 0
Retained earnings: -8432257.857142858
Receivables turnover: 2.6336080047086523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.542112324123457
FCF margin (%): -0.1778049469871757
Revenue growth (%): 7.72676807616569
Rule of 40 score: 7.548963129178514
Financial ratios for EVGO — annual report dated 2021-12-31
Capital expenditures: 65003000
Buffett classification: The Gruesome
Stock price: 9.94
Shares outstanding: 141059365
Market cap (USD): 1402130088.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVGO — annual report dated 2022-12-31
Total revenue: 54588000
Gross profit: -5651000
Operating income: -149503000
Net income: -27575000
Capital expenditures: 0
Operating cash flow: -58794000
Depreciation & amortization: 35918000
Net tangible assets: -449764000
Owner earnings: 8343000
Buffett classification: The Gruesome
Stock price: 4.47
Shares outstanding: 141059365
Book value: 517126000
P/B ratio: 1.2193070190823898
Market cap (USD): 630535361.55
Debt to equity: 0.09793938034444216
Current ratio: 3.153975613944702
Quick ratio: 3.153975613944702
Interest coverage ratio: -7119.190476190476
COGS to revenue (%): 110.35209203487946
SG&A to revenue (%): 232.12610830219097
Free cash flow (dilution-adjusted): -284093000
Buyback yield (%): 0
Retained earnings: -375660000
Receivables turnover: 2.8601068846274758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.27333240968338
FCF margin (%): -520.4312303070271
Rule of 40 score: -520.4312303070271
Financial ratios for EVGO — annual report dated 2023-12-31
Total revenue: 160953000
Gross profit: 9714000
Operating income: -153407000
Net income: -42427000
Capital expenditures: 15273000
Operating cash flow: -37055000
Depreciation & amortization: 51961000
Net tangible assets: -240638000
Owner earnings: -5739000
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 141059365
Book value: 540375000
P/B ratio: 0.9345223718713856
Market cap (USD): 504992526.7
Debt to equity: 0.12584779088595882
Current ratio: 2.9928928783283153
Quick ratio: 2.9928928783283153
COGS to revenue (%): 93.96469776891391
SG&A to revenue (%): 88.85513162227483
Free cash flow (dilution-adjusted): -225675000
Buyback yield (%): 0
Retained earnings: -248547000
Receivables turnover: 3.6432015210846784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.387711967788842
FCF margin (%): -140.2117388305903
Revenue growth (%): 194.8505165970543
Rule of 40 score: 54.63877776646402
Financial ratios for EVGO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.14
Shares outstanding: 141059365
Market cap (USD): 583985771.0999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVGO — annual report dated 2024-12-31
Total revenue: 256825000
Gross profit: 29367000
Operating income: -131570000
Net income: -44037000
Capital expenditures: 0
Operating cash flow: -7256000
Depreciation & amortization: 65795000
Net tangible assets: -325911000
Owner earnings: 21758000
Buffett classification: The Gruesome
Stock price: 4.05
Shares outstanding: 141059365
Book value: 443731000
P/B ratio: 1.2874701750610167
Market cap (USD): 571290428.25
Debt to equity: 0.2036571706732232
Current ratio: 1.8434162103940401
Quick ratio: 1.8434162103940401
Interest coverage ratio: -1802.3287671232877
COGS to revenue (%): 88.56536552126934
SG&A to revenue (%): 54.952204808721895
Free cash flow (dilution-adjusted): -124002000
Buyback yield (%): 0
Retained earnings: -256139000
Receivables turnover: 4.039335650587439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.003366789388622
FCF margin (%): -48.28268276063467
Revenue growth (%): 59.565214690002676
Rule of 40 score: 11.282531929368005
Financial ratios for EVGO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.05
Shares outstanding: 141059365
Market cap (USD): 571290428.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVGO — quarterly report dated 2025-03-31
Total revenue: 75287000
Gross profit: 9323000
Operating income: -33400000
Net income: -11300000
Capital expenditures: 14992000
Operating cash flow: -10246000
Depreciation & amortization: 20050000
Net tangible assets: -104586000
Owner earnings: -6242000
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 141059365
Book value: 422874000
P/B ratio: 0.8873042818901139
Market cap (USD): 375217910.90000004
Debt to equity: 0.3985868130932618
Current ratio: 2.2658683282685734
Quick ratio: 2.2658683282685734
Interest coverage ratio: -64.60348162475822
COGS to revenue (%): 87.61672001806421
SG&A to revenue (%): 51.307662677487485
Free cash flow (dilution-adjusted): -30732000
Buyback yield (%): 0
Retained earnings: -42155000
Receivables turnover: 1.2118241666264264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.4827160427549115
FCF margin (%): -40.819796246363914
Rule of 40 score: -40.819796246363914
Financial ratios for EVGO — quarterly report dated 2025-06-30
Total revenue: 98030000
Gross profit: 13908000
Operating income: -30812000
Net income: -12928000
Capital expenditures: 26199000
Operating cash flow: 14089000
Depreciation & amortization: 18466000
Net tangible assets: -296069000
Owner earnings: -20661000
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 141059365
Book value: 400580000
P/B ratio: 1.2853030162514354
Market cap (USD): 514866682.25
Debt to equity: 0.47773478456238455
Current ratio: 2.136063173396755
Quick ratio: 2.136063173396755
Interest coverage ratio: -33.896589658965894
COGS to revenue (%): 85.81250637559931
SG&A to revenue (%): 41.41181271039478
Free cash flow (dilution-adjusted): -19141000
Buyback yield (%): 0
Retained earnings: -230170000
Receivables turnover: 2.0380881099399155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.127495291397524
FCF margin (%): -19.525655411608692
Revenue growth (%): 30.208402513050064
Rule of 40 score: 10.682747101441372
Financial ratios for EVGO — quarterly report dated 2025-09-30
Total revenue: 92299000
Gross profit: 12560000
Operating income: -34084000
Net income: -12319000
Capital expenditures: 26152000
Operating cash flow: -22828000
Depreciation & amortization: 17168000
Net tangible assets: -492787000
Owner earnings: -21303000
Buffett classification: The Gruesome
Stock price: 4.73
Shares outstanding: 141059365
Book value: 389225000
P/B ratio: 1.714203343695806
Market cap (USD): 667210796.45
Debt to equity: 0.6728935705568758
Current ratio: 2.1339448991216234
Quick ratio: 2.1339448991216234
Interest coverage ratio: -17.89186351706037
COGS to revenue (%): 86.39205191822231
SG&A to revenue (%): 47.02326135711113
Free cash flow (dilution-adjusted): -56013000
Buyback yield (%): 0
Retained earnings: -428149000
Receivables turnover: 1.7120307167235496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.269022035237843
FCF margin (%): -60.68646464208713
Revenue growth (%): -5.846169539936754
Rule of 40 score: -66.53263418202388
Financial ratios for EVGO — annual report dated 2025-12-31
Total revenue: 384086000
Gross profit: 80777000
Operating income: -110663000
Net income: -41351000
Capital expenditures: 116707000
Operating cash flow: -7728000
Depreciation & amortization: 74016000
Net tangible assets: -180377000
Owner earnings: -84042000
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 141059365
Book value: 385944000
P/B ratio: 1.063581120965736
Market cap (USD): 410482752.15000004
Debt to equity: 0.8063605082602657
Current ratio: 2.1909223925156294
Quick ratio: 2.1909223925156294
Interest coverage ratio: -18.005694760820045
COGS to revenue (%): 78.96903297698952
SG&A to revenue (%): 46.04906192883885
Free cash flow (dilution-adjusted): -151545000
Buyback yield (%): 0
Retained earnings: -124687000
Receivables turnover: 6.612026373323693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.34079960651374
FCF margin (%): -39.456007248376665
Revenue growth (%): 49.551640221941014
Rule of 40 score: 10.09563297356435
Financial ratios for EVGO — quarterly report dated 2025-12-31
Total revenue: 118470000
Gross profit: 44986000
Operating income: -12367000
Net income: -4803000
Capital expenditures: 49364000
Operating cash flow: 11257000
Depreciation & amortization: 18332000
Net tangible assets: -180377000
Owner earnings: -35835000
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 141059365
Book value: 385944000
P/B ratio: 1.063581120965736
Market cap (USD): 410482752.15000004
Debt to equity: 0.8063605082602657
Current ratio: 2.1909223925156294
Quick ratio: 2.1909223925156294
Interest coverage ratio: -4.393250444049734
COGS to revenue (%): 62.0275175149827
SG&A to revenue (%): 45.7854309107791
Free cash flow (dilution-adjusted): -45659000
Buyback yield (%): 0
Retained earnings: -124687000
Receivables turnover: 2.0394566957599545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4908837527787555
FCF margin (%): -38.54055879125517
Revenue growth (%): 28.354586723583136
Rule of 40 score: -10.185972067672036
Financial ratios for FEL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.015037593984962405
Shares outstanding: 866003825
Market cap (USD): 13022613.909774436
Buyback yield (%): 0.20056493399437356
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FEL.AX — annual report dated 2022-06-30
Operating income: -258882.06896551725
Net income: -258680.68965517243
Capital expenditures: 159270.3448275862
Net tangible assets: 2958660
Owner earnings: -417951.0344827586
Return on net tangible assets (%): -14.12636242362281
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 866003825
Book value: 2958660
P/B ratio: 2.018630113772381
Market cap (USD): 5972440.172413793
Debt to equity: 0
Current ratio: 6.582970671712393
Quick ratio: 6.582970671712393
Free cash flow (dilution-adjusted): -448117.9310344828
Buyback yield (%): 0.6408747674988619
Retained earnings: -10481420.689655174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.74997698165782
Rule of 40 score: 0
Financial ratios for FEL.AX — annual report dated 2023-06-30
Operating income: -517325.1655629139
Net income: -508981.45695364237
Capital expenditures: 71716.55629139073
Net tangible assets: 3598990.728476821
Owner earnings: -580698.0132450331
Return on net tangible assets (%): -16.13502387350685
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 866003825
Book value: 3598990.728476821
P/B ratio: 1.5935369389799496
Market cap (USD): 5735124.6688741725
Debt to equity: 0
Current ratio: 19.346834760331696
Quick ratio: 19.346834760331696
Free cash flow (dilution-adjusted): -523596.68874172185
Buyback yield (%): 2.283142340624188
Retained earnings: -10546013.245033113
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.374173333362778
Rule of 40 score: 0
Financial ratios for FEL.AX — annual report dated 2024-06-30
Operating income: -1688478
Net income: -1677132
Capital expenditures: 65792.66666666667
Net tangible assets: 2565602.6666666665
Owner earnings: -1742924.6666666667
Return on net tangible assets (%): -67.93431770676884
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 866003825
Book value: 2565602.666666667
P/B ratio: 2.2502934333297646
Market cap (USD): 5773358.833333334
Debt to equity: 0
Current ratio: 24.253257114314657
Quick ratio: 24.253257114314657
Free cash flow (dilution-adjusted): -411738
Buyback yield (%): 0.6851932784477018
Retained earnings: -12173670.666666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.81213926604379
Rule of 40 score: 0
Financial ratios for FG — annual report dated 2022-12-31
Total revenue: 2239000000
Net income: 635000000
Capital expenditures: 32000000
Operating cash flow: 3171000000
Depreciation & amortization: 324000000
Net tangible assets: -2773000000
Owner earnings: 927000000
Return on net tangible assets (%): -33.429498737829064
Buffett classification: The Gruesome
Stock price: 18.14
P/E ratio: 3.7846893206299215
Shares outstanding: 132484990
Book value: 2405000000
P/B ratio: 0.9992838746777547
Market cap (USD): 2403277718.6
Debt to equity: 0.46860706860706863
Effective tax rate (%): 19.924337957124845
COGS to revenue (%): 0
SG&A to revenue (%): 7.012058954890577
Free cash flow (dilution-adjusted): 3127000000
Buyback yield (%): 0
Retained earnings: 2061000000
Receivables turnover: 0.41120293847566575
Capitalized R&D asset: 0
FCF margin (%): 139.6605627512282
Rule of 40 score: 139.6605627512282
Financial ratios for FG — annual report dated 2023-12-31
Total revenue: 4271000000
Net income: -58000000
Capital expenditures: 27000000
Operating cash flow: 5834000000
Depreciation & amortization: 412000000
Net tangible assets: -2853000000
Owner earnings: 327000000
Buffett classification: The Gruesome
Stock price: 43.01
Shares outstanding: 132484990
Book value: 3103000000
P/B ratio: 1.8363452851756363
Market cap (USD): 5698179419.9
Debt to equity: 0.5688043828553013
COGS to revenue (%): 0
SG&A to revenue (%): 5.4319831421212825
Free cash flow (dilution-adjusted): 5784000000
Buyback yield (%): 0.3158903690736346
Retained earnings: 1926000000
Receivables turnover: 0.47524201624568824
Capitalized R&D asset: 0
FCF margin (%): 135.42495902598924
Revenue growth (%): 90.75480125055829
Rule of 40 score: 226.17976027654754
Financial ratios for FG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.5
Shares outstanding: 132484990
Market cap (USD): 5630612075
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FG — annual report dated 2024-12-31
Total revenue: 5421000000
Net income: 642000000
Capital expenditures: 24000000
Operating cash flow: 5999000000
Depreciation & amortization: 569000000
Net tangible assets: -3800000000
Owner earnings: 1187000000
Return on net tangible assets (%): -31.236842105263158
Buffett classification: The Gruesome
Stock price: 39.58
P/E ratio: 8.16784408753894
Shares outstanding: 132484990
Book value: 4076000000
P/B ratio: 1.2864955604023551
Market cap (USD): 5243755904.2
Debt to equity: 0.5375368007850834
Effective tax rate (%): 17.480719794344473
COGS to revenue (%): 0
SG&A to revenue (%): 5.460247186865892
Free cash flow (dilution-adjusted): 5946000000
Buyback yield (%): 0.22884360407372453
Retained earnings: 2440000000
Receivables turnover: 0.4054903134116239
Capitalized R&D asset: 0
FCF margin (%): 109.68456004427227
Revenue growth (%): 26.925778506204633
Rule of 40 score: 136.6103385504769
Financial ratios for FG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.58
Shares outstanding: 132484990
Market cap (USD): 5243755904.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FG — quarterly report dated 2025-03-31
Total revenue: 854000000
Net income: -21000000
Capital expenditures: 5000000
Operating cash flow: 956000000
Depreciation & amortization: 153000000
Net tangible assets: -3537000000
Owner earnings: 127000000
Buffett classification: The Gruesome
Stock price: 34.61
Shares outstanding: 132484990
Book value: 4485000000
P/B ratio: 1.0223646608472687
Market cap (USD): 4585305503.9
Debt to equity: 0.5001114827201784
COGS to revenue (%): 0
SG&A to revenue (%): 7.845433255269321
Free cash flow (dilution-adjusted): 943000000
Buyback yield (%): 0.06542639301674384
Retained earnings: 2389000000
Receivables turnover: 0.057914010579140106
Capitalized R&D asset: 0
FCF margin (%): 110.4215456674473
Rule of 40 score: 110.4215456674473
Financial ratios for FG — quarterly report dated 2025-06-30
Total revenue: 1304000000
Net income: 42000000
Capital expenditures: 4000000
Operating cash flow: 1620000000
Depreciation & amortization: 158000000
Net tangible assets: -3684000000
Owner earnings: 196000000
Return on net tangible assets (%): -5.320304017372422
Buffett classification: The Gruesome
Stock price: 30.92
P/E ratio: 195.06837575238097
Shares outstanding: 132484990
Book value: 4557000000
P/B ratio: 0.8989326071538293
Market cap (USD): 4096435890.8
Debt to equity: 0.4924292297564187
Effective tax rate (%): 26.31578947368421
COGS to revenue (%): 0
SG&A to revenue (%): 5.904907975460123
Free cash flow (dilution-adjusted): 1610000000
Buyback yield (%): 0
Retained earnings: 2394000000
Receivables turnover: 0.08262054108851295
Capitalized R&D asset: 0
FCF margin (%): 123.46625766871166
Revenue growth (%): 52.69320843091335
Rule of 40 score: 176.159466099625
Financial ratios for FG — quarterly report dated 2025-09-30
Total revenue: 1603000000
Net income: 120000000
Capital expenditures: 3000000
Operating cash flow: 937000000
Depreciation & amortization: 180000000
Net tangible assets: -3453000000
Owner earnings: 297000000
Return on net tangible assets (%): -8.601216333622936
Buffett classification: The Gruesome
Stock price: 30.43
P/E ratio: 28.59232798368794
Shares outstanding: 132484990
Book value: 4940000000
P/B ratio: 0.8160968108704454
Market cap (USD): 4031518245.7
Debt to equity: 0.454251012145749
Effective tax rate (%): 8.396946564885496
COGS to revenue (%): 0
SG&A to revenue (%): 4.9282595134123515
Free cash flow (dilution-adjusted): 926000000
Buyback yield (%): 0
Retained earnings: 2478000000
Receivables turnover: 0.094795978710822
Capitalized R&D asset: 0
FCF margin (%): 57.766687461010605
Revenue growth (%): 22.929447852760738
Rule of 40 score: 80.69613531377135
Financial ratios for FG — annual report dated 2025-12-31
Total revenue: 5429000000
Net income: 271000000
Capital expenditures: 15000000
Operating cash flow: 4681000000
Depreciation & amortization: 665000000
Net tangible assets: -3651000000
Owner earnings: 921000000
Return on net tangible assets (%): -25.22596548890715
Buffett classification: The Gruesome
Stock price: 30.24
P/E ratio: 14.783564935793358
Shares outstanding: 132484990
Book value: 4917000000
P/B ratio: 0.8147948134228187
Market cap (USD): 4006346097.6
Debt to equity: 0.4598332316453122
Effective tax rate (%): 16.09907120743034
COGS to revenue (%): 0
SG&A to revenue (%): 5.396942346656843
Free cash flow (dilution-adjusted): 4635000000
Buyback yield (%): 0.24960399716815518
Retained earnings: 2568000000
Receivables turnover: 0.3079759473564783
Capitalized R&D asset: 0
FCF margin (%): 85.37483882851353
Revenue growth (%): 0.14757424829367274
Rule of 40 score: 85.52241307680721
Financial ratios for FG — quarterly report dated 2025-12-31
Total revenue: 1668000000
Net income: 130000000
Capital expenditures: 3000000
Operating cash flow: 1168000000
Depreciation & amortization: 174000000
Net tangible assets: -3651000000
Owner earnings: 301000000
Return on net tangible assets (%): -8.244316625582032
Buffett classification: The Gruesome
Stock price: 30.24
P/E ratio: 14.783564935793358
Shares outstanding: 132484990
Book value: 4917000000
P/B ratio: 0.8147948134228187
Market cap (USD): 4006346097.6
Debt to equity: 0.4598332316453122
Effective tax rate (%): 19.25465838509317
COGS to revenue (%): 0
SG&A to revenue (%): 4.1966426858513195
Free cash flow (dilution-adjusted): 1156000000
Buyback yield (%): 0.17472279801770865
Retained earnings: 2568000000
Receivables turnover: 0.09462219196732471
Capitalized R&D asset: 0
FCF margin (%): 69.30455635491607
Revenue growth (%): 4.054897067997505
Rule of 40 score: 73.35945342291357
Financial ratios for GMI.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 362.9010989010989
Shares outstanding: 330000
Market cap (USD): 119757362.63736264
Buyback yield (%): 0
Retained earnings: 129440659.34065934
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMI.SW — annual report dated 2022-12-31
Total revenue: 157603260.86956522
Gross profit: 48783695.652173914
Operating income: 7534782.608695651
Net income: 7958695.652173913
Capital expenditures: 848913.0434782609
Operating cash flow: 10267391.304347826
Depreciation & amortization: 5883695.652173913
Net tangible assets: 122373913.04347825
Owner earnings: 12993478.260869564
Return on net tangible assets (%): 10.617849783272934
Capex to operating income (%): 11.266589728794001
Buffett classification: The Great
Stock price: 265.77173913043475
P/E ratio: 11.019980879541109
Shares outstanding: 330000
Book value: 122427173.91304348
P/B ratio: 0.7163824101284703
Market cap (USD): 87704673.91304347
Debt to equity: 0
Current ratio: 3.2257650441569106
Quick ratio: 1.4451632778804677
Effective tax rate (%): 14.642107717416646
Interest coverage ratio: 577.6666666666666
COGS to revenue (%): 69.04651884547742
Free cash flow (dilution-adjusted): 5001086.956521739
Buyback yield (%): 0
Retained earnings: 132764130.43478261
Inventory turnover: 2.886876784220998
Receivables turnover: 9.833502882332995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.672714179330436
FCF margin (%): 3.17321286940929
Rule of 40 score: 3.17321286940929
Financial ratios for GMI.SW — annual report dated 2023-12-31
Total revenue: 176413095.23809525
Gross profit: 53483333.333333336
Operating income: 8091666.666666667
Net income: 7658333.333333334
Capital expenditures: 6317857.142857143
Operating cash flow: 16069047.61904762
Depreciation & amortization: 5965476.19047619
Net tangible assets: 135794047.6190476
Owner earnings: 7305952.3809523815
Return on net tangible assets (%): 5.380171302830793
Capex to operating income (%): 78.07856407238486
Buffett classification: The Gruesome
Stock price: 291.3095238095238
P/E ratio: 12.552619306699826
Shares outstanding: 330000
Book value: 135955952.3809524
P/B ratio: 0.7070830013222069
Market cap (USD): 96132142.85714285
Debt to equity: 0
Current ratio: 3.5476190476190474
Quick ratio: 1.7637906647807637
Effective tax rate (%): 13.677191072400651
Interest coverage ratio: 617.9090909090909
COGS to revenue (%): 69.68290065930209
Free cash flow (dilution-adjusted): 9696428.57142857
Buyback yield (%): 0
Retained earnings: 147173809.52380952
Inventory turnover: 3.411556759614114
Receivables turnover: 11.818087566791611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.504401415579473
FCF margin (%): 5.496433560298811
Revenue growth (%): 11.934927148555213
Rule of 40 score: 17.431360708854022
Financial ratios for GMI.SW — annual report dated 2024-12-31
Total revenue: 161161111.1111111
Gross profit: 48408888.88888889
Operating income: 5920000
Net income: 6028888.888888889
Capital expenditures: 8367777.777777778
Operating cash flow: 10588888.888888888
Depreciation & amortization: 5570000
Net tangible assets: 128736666.66666666
Owner earnings: 3231111.11111111
Return on net tangible assets (%): 2.5098607838567957
Capex to operating income (%): 141.3475975975976
Buffett classification: The Gruesome
Stock price: 279.84444444444443
P/E ratio: 15.317692591227422
Shares outstanding: 330000
Book value: 128848888.8888889
P/B ratio: 0.7167207064261322
Market cap (USD): 92348666.66666666
Debt to equity: 0
Current ratio: 3.5988481282083384
Quick ratio: 1.6868035557781396
Effective tax rate (%): 12.752872633112155
Interest coverage ratio: 409.84615384615387
COGS to revenue (%): 69.96242545416939
Free cash flow (dilution-adjusted): 2024444.4444444445
Buyback yield (%): 0
Inventory turnover: 3.3224306715122944
Receivables turnover: 12.620290611676673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.278796347604019
FCF margin (%): 1.2561618807956152
Revenue growth (%): -8.645607689383471
Rule of 40 score: -7.3894458085878565
Financial ratios for GMI.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 128736666.66666666
Buffett classification: The Gruesome
Stock price: 279.84444444444443
Shares outstanding: 330000
Book value: 128848888.8888889
P/B ratio: 0.7167207064261322
Market cap (USD): 92348666.66666666
Debt to equity: 0
Current ratio: 3.5988481282083384
Quick ratio: 1.6868035557781396
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMI.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 144886250
Buffett classification: The Gruesome
Stock price: 274.84999999999997
Shares outstanding: 330000
Book value: 145378750
P/B ratio: 0.6238910432233046
Market cap (USD): 90700499.99999999
Debt to equity: 0.1461699182308281
Current ratio: 3.7246036052330136
Quick ratio: 1.5477783806595526
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GTL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1450613213767638
Shares outstanding: 157296781
Market cap (USD): 22817678.900171436
Buyback yield (%): 0
Retained earnings: -1078083871.8185415
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GTL.NS — annual report dated 2023-03-31
Total revenue: 22695493.30085262
Gross profit: 19643118.14859927
Operating income: 7844092.570036542
Net income: 6968331.303288673
Capital expenditures: 14386114.49451888
Operating cash flow: 2202192.4482338615
Depreciation & amortization: 523751.5225334958
Net tangible assets: -759146163.2155908
Owner earnings: -6894031.668696711
Capex to operating income (%): 183.4006211180124
Buffett classification: The Gruesome
Stock price: 0.0584652862362972
P/E ratio: 1.319742263240692
Shares outstanding: 157296781
Book value: -759073081.6077954
Market cap (USD): 9196401.325213155
Debt to equity: -0.9351475210967927
Current ratio: 0.03300225466334468
Quick ratio: 0.03300225466334468
Interest coverage ratio: 2.662257131045887
COGS to revenue (%): 13.449256695110826
SG&A to revenue (%): 8.8659904470563
Free cash flow (dilution-adjusted): 1904993.9098660173
Buyback yield (%): 0
Retained earnings: -988781973.2034105
Receivables turnover: 5.6191194209891435
Capitalized R&D asset: 0
FCF margin (%): 8.39371008425911
Rule of 40 score: 8.39371008425911